- Package
- 1 g
- Purity
- 99%
- Price
- Request review
- Availability
- Shipping review required
- Delivery
- Shipping review required
CAS Number: 1609392-27-9
Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.
Available options
Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.
CAS Number
1609392-27-9
PubChem CID
134821691
Molecular Formula
C20H22N8O3
Molecular Weight
425.5 g/mol
Exact Mass
425.200317
InChIKey
BZZKEPGENYLQSC-FIBGUPNXSA-N
IUPAC Name
6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
SMILES String
[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4
No physical property values available.
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Structural features
Deucravacitinib (CAS 1609392-27-9) is listed in the Life Science portfolio, with molecular formula C20H22N8O3 and molecular weight 425. 50 g/mol.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Intended for life-science research and analytical workflows; structure-derived tags include nitrogen-containing heterocycle.
Documentation needs
COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.
ChEMBL reports experimental activity evidence for: Non-receptor tyrosine-protein kinase TYK2 (Homo sapiens) — 32 assays; Tyrosine-protein kinase JAK1 (Homo sapiens) — 16 assays; Tyrosine-protein kinase JAK3 (Homo sapiens) — 6 assays; JAK1/TYK2 (Homo sapiens) — 2 assays; Tyrosine-protein kinase JAK2 (Homo sapiens) — 11 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
Non-receptor tyrosine-protein kinase TYK2
Homo sapiens · SINGLE PROTEIN · 32 qualifying assays · 16 documents · best pChEMBL 10.7
Experimental evidence source: ChEMBL
Tyrosine-protein kinase JAK1
Homo sapiens · SINGLE PROTEIN · 16 qualifying assays · 6 documents · best pChEMBL 9.64
Experimental evidence source: ChEMBL
Tyrosine-protein kinase JAK3
Homo sapiens · SINGLE PROTEIN · 6 qualifying assays · 4 documents · best pChEMBL 8.52
Experimental evidence source: ChEMBL
JAK1/TYK2
Homo sapiens · PROTEIN COMPLEX · 2 qualifying assays · 2 documents · best pChEMBL 8.3
Experimental evidence source: ChEMBL
Tyrosine-protein kinase JAK2
Homo sapiens · SINGLE PROTEIN · 11 qualifying assays · 5 documents · best pChEMBL 8
Experimental evidence source: ChEMBL
Safety and handling reference content is available through documentation requests.
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Preliminary Safety Reference
For supplier-issued SDS or COA, submit a documentation request.
Safety Reference / SDS RequestCatalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Deucravacitinib is identified by CAS 1609392-27-9, with molecular formula C20H22N8O3, molecular weight 425.5, InChIKey BZZKEPGENYLQSC-FIBGUPNXSA-N.
ChEMBL contains qualifying experimental assay evidence associated with Non-receptor tyrosine-protein kinase TYK2, Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK3, JAK1/TYK2, Tyrosine-protein kinase JAK2. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.